Sunmax Biotechnology Revenue

In the year 2024, Sunmax Biotechnology had annual revenue of 1.82B TWD with 7.64% growth. Sunmax Biotechnology had revenue of 479.18M in the quarter ending December 31, 2024, with 18.46% growth.

Revenue

1.82B

Revenue Growth

+7.64%

P/S Ratio

14.20

Revenue / Employee

n/a

Employees

n/a

Market Cap

25.82B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.82B	129.03M	7.64%
Dec 31, 2023	1.69B	288.91M	20.64%
Dec 31, 2022	1.40B	364.42M	35.19%
Dec 31, 2021	1.04B	179.81M	21.01%
Dec 31, 2020	855.85M	261.71M	44.05%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
PharmaEssentia	9.73B
Caliway Biopharmaceuticals	44.43M
Bora Pharmaceuticals Co., LTD.	19.25B
Lotus Pharmaceutical	18.58B
Oneness Biotech	117.93M
Polaris Group	107.00M
Lumosa Therapeutics	39.15M
Pegavision	6.82B

Revenue Rankings